Stocks in news: Xencor (NASDAQ:XNCR), Biota Pharmaceuticals (NASDAQ:BOTA), Allison Transmission Holdings (NYSE:ALSN), Semtech Corporation (NASDAQ:SMTC), First Capital Inc. (NASDAQ:FCAP)


Xencor, Inc. (NASDAQ: XNCR), announced that it will webcast presentation by Bassil Dahiyat, Ph.D., president and chief executive officer, at 2015 Leerink Global Healthcare Conference on Thursday, February 12, 2015. On Tuesday shares of Xencor, Inc. (NASDAQ:XNCR) closed at $15.44.

On 5 February, Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) reported net income of $6.5 million for the three month period ended December 31, 2014, as compared to a net loss of $0.1 million in the same period of the prior fiscal year. Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) in last trading activity moved up 7.85% to close at $2.61. Company weekly performance is 6.53% while its quarterly performance stands at 13.48%. Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) is -63.08% away from its 52 week high.

Allison Transmission (NYSE: ALSN) reported Q4 EPS of $0.28, $0.02 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $544 million versus the consensus estimate of $513.85 million. On last trading day Allison Transmission Holdings, Inc. (NYSE:ALSN) decreased -3.54% to close at $31.35. Its volatility for the week is 2.64% while volatility for the month is 2.34%. ALSN’s sales growth for past 5 years was -1.30% and its EPS growth for past 5 years was 20.00%. Allison Transmission Holdings, Inc. (NYSE:ALSN) monthly performance is -5.74%.

On 5 February, Semtech Corp. (NASDAQ:SMTC), announced the RClamp1255P, a high-performance, low capacitance transient voltage suppression (TVS) device. The RClamp1255P is a highly integrated device that replaces multiple discrete components while providing complete VBUS surge protection, and ESD protection for USB data lines and ID line. Semtech Corporation (NASDAQ:SMTC) has 0.80% insider ownership while its institutional ownership stands at 99.10%. In last trading activity company’s stock closed at $26.96.

On 29 January, First Capital, Inc. (NASDAQ:FCAP) reported record net income of $5.6 million, or $2.03 per diluted share, for the year ended December 31, 2014, compared to net income of $5.1 million, or $1.82 per diluted share, for the year ended December 31, 2013. On last trading day First Capital Inc. (NASDAQ:FCAP) moved up 0.17% to close at $23.90. Its volatility for the week is 1.55% while volatility for the month is 2.21%. FCAP’s sales growth for past 5 years was -6.50% and its EPS growth for past 5 years was 7.50%. First Capital Inc. (NASDAQ:FCAP) monthly performance is -3.43%.


Leave a Reply

Your email address will not be published. Required fields are marked *